EW - Company ID 0001099800
Edwards Lifesciences Corp trades as EW and has a market capitalization of $52.59 B, making it the #311 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $6.07B, up 11.5% from the prior year and net income of $1.07B. This page tracks Edwards Lifesciences Corp through 2,569 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-10
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years Edwards Lifesciences Corp's revenue grew from $2.96B to $6.07B, a compound annual growth rate of 8.3%. Net profit margin compressed from 28.7% to 17.7% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider sale notice | 144 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider sale notice | 144 | 2026-05-15 |
| Insider sale notice | 144 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
The largest companies sharing Edwards Lifesciences Corp's SEC industry classification (orthopedic, prosthetic & surgical appliances & supplies).
Edwards Lifesciences Corp (EW) has a market capitalization of $52.59 B as of 2026-07-10, ranking #311 among US-listed companies.
Edwards Lifesciences Corp reported revenue of $6.07B for fiscal year 2025, an increase of 11.5% year over year.
Yes. Edwards Lifesciences Corp reported net income of $1.07B in its latest fiscal year.